Phenotype of CD34+ stem cell subpopulations in peripheral blood of patients undergoing mobilization of PBSC with cyclophosphamide, etoposide and SC-70935 or G-CSF

被引：0
|
作者：
Klabusay, M
Lysak, D
Kovarova, L
Koristek, Z
Mayer, J
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S253 / S253
页数：1
相关论文
共 50 条
  • [21] A phase II study of peripheral blood stem cell (PBSC) mobilization using stem cell factor (SCF), filgrastin (G-CSF), and cyclophosphamide (CY) in patients at high risk for mobilization failure.
    Chen, CI
    Nagy, T
    Yi, QL
    Keating, A
    Crump, M
    BLOOD, 2004, 104 (11) : 788A - 788A
  • [22] Analysis of subpopulations of CD34+cells in peripheral blood mobilized by G-CSF
    Klabusay, M
    Kovarova, L
    Koristek, Z
    Vorlicek, J
    BONE MARROW TRANSPLANTATION, 2002, 29 : S141 - S141
  • [23] The possible cost effectiveness of peripheral blood stem cell mobilization with cyclophosphamide and the late addition of G-CSF
    Min, YJ
    Kim, SW
    Suh, C
    Park, J
    Kim, HJ
    Kim, JG
    Kim, TW
    Lee, JH
    Kim, SB
    Lee, KH
    Lee, JS
    Kim, WK
    Kim, SH
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (01) : 49 - 52
  • [24] Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilization
    Williams, O
    Demirer, T
    Lilleby, K
    Buckner, CD
    Bensinger, WI
    JOURNAL OF CLINICAL APHERESIS, 1998, 13 (01) : 1 - 6
  • [25] Peripheral blood stem cell mobilization and engraftment using moderate dose cyclophosphamide, etoposide, and G-CSF.
    Richman, C
    Wun, T
    Malik, R
    Schuermann, T
    BLOOD, 1996, 88 (10) : 3692 - 3692
  • [26] Mobilisation of PBSC with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with lymphoma.
    McQuaker, IG
    Haynes, AP
    Stainer, C
    Byrne, JL
    Russell, NH
    BONE MARROW TRANSPLANTATION, 1999, 23 : S217 - S217
  • [27] Progenitor cell mobilisation - Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma
    Mollee, P
    Pereira, D
    Nagy, T
    Song, K
    Saragosa, R
    Keating, A
    Crump, M
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 273 - 278
  • [28] Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction
    Leone, Antonio Maria
    Rutella, Sergio
    Bonanno, Giuseppina
    Contemi, Anna Maria
    de Ritis, Daniela G.
    Giannico, Maria Benedetta
    Rebuzzi, Antonio G.
    Leone, Giuseppe
    Crea, Filippo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 111 (02) : 202 - 208
  • [29] PERIPHERAL BLOOD STEM CELL MOBILIZATION USING G-CSF ALONE FOR MM WITH THE MINIMAL RESIDUAL DISEASE COMPARED TO CYCLOPHOSPHAMIDE PLUS G-CSF
    Jang, J. E.
    Hyun, S. Y.
    Hwang, D. Y.
    Kim, Y. D.
    Kim, S. J.
    Cheong, J. W.
    Min, Y. H.
    Kim, J. S.
    HAEMATOLOGICA, 2012, 97 : 609 - 609
  • [30] A pilot study of cyclophosphamide, carboplatin, etoposide (CCE), and G-CSF with or without rituximab for cytoreduction and peripheral blood stem cell mobilization in patients with relapsed or refractory lymphomas
    Stevenson, DE
    Haroff, AL
    Ririe, DW
    Splichal, JE
    Ornstein, DL
    Heller, BJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 121 - 121
12345